Breaking Down CELEBRATE and POLY-HF: Two Paths to Better Cardiac Care

In this solo episode, Craig Beavers breaks down new data from the CELEBRATE STEMI (NCT04825743) trial and the POLY-HF (NCT04633005) polypill study. He highlights what these findings could mean for real-world practice, from early antiplatelet strategies to improving adherence and outcomes in heart failure.

Show Notes:

• Patient Perspectives on a Polypill Strategy for Heart Failure with Reduced Ejection Fraction: A Convergent-Parallel Mixed Methods Study Embedded in a Randomized Clinical Trial
• Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction